Sisu Pharma
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sisu Pharma - overview
Established
2019
Location
-, NC, US
Primary Industry
Pharmaceuticals
About
Established in 2019 and based in US, Sisu Pharma operates as a medical drugs producer that focuses on cancer treatment. Dr. Sean O'Brien is the founder and CEO of the company. In October 2017, the company raised USD 1.
7 million in seed funding from new investor Viva Ventures Biotech. The company provides medical drugs for patients with prostate cancer. The company develops HI-LiTe platform. HI-LiTe platform includes heat shock factor 1 (HSF1) and hyperactivation in cancer.
Current Investors
Viva Ventures Biotech
Primary Industry
Pharmaceuticals
Sub Industries
Healthcare, Pharmaceutical Research & Development
Website
www.sisupharma.com
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Sisu Pharma - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.